Language:English
Language:

Xcessbio

Place your promotion here

You have no items in your shopping cart.

ME0328, PARP-3 Inhibitor

ME0328, PARP-3 Inhibitor

$109.00
A potent, selective and cell permeable PARP-3 inhibitor.
Catalog No. Unit Price Qty
M60329-2s 2 mg solid $109.00

Details

Product Information
Molecular Weight: 321.37
Formula: C19H19N3O2
Purity: ≥98%
CAS#: 1445251-22-8
Solubility: DMSO up to 100 mM
Chemical Name: (S)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-(1-phenylethyl)propanamide
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

ME0328 is a potent, selective and cell permeable PARP-3 inhibitor with IC50 of 0.89 μM. It has good selectivity against PARP-1, PARP-2 and other ARDT enzymes. Enhances CRISPR-Cas9-mediated HER2 mutation frequency, resulting in increased reduction in proliferation of HER2-positive breast cancer cells.

How to Use:

In vitro: ME0328 was used at 10 µM in vitro and cellular assays.
In vivo: n/a

Reference:

  • 1. Lindgren AE, et al. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3. (2013) ACS Chem Biol. 8(8):1698-703. 
  • 2. Wang H, et al. CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation. (2017) Cancer Lett. 385:137-143. 
  • 3. Day TA, et al. PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA. (2017) Nat Commun. 8:15110. 


ME0328_spec.pdf 
ME0328_MSDS.pdf     

Products are for research use only. Not for human use. 

Description

Details

Product Information
Molecular Weight: 321.37
Formula: C19H19N3O2
Purity: ≥98%
CAS#: 1445251-22-8
Solubility: DMSO up to 100 mM
Chemical Name: (S)-3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-(1-phenylethyl)propanamide
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:

ME0328 is a potent, selective and cell permeable PARP-3 inhibitor with IC50 of 0.89 μM. It has good selectivity against PARP-1, PARP-2 and other ARDT enzymes. Enhances CRISPR-Cas9-mediated HER2 mutation frequency, resulting in increased reduction in proliferation of HER2-positive breast cancer cells.

How to Use:

In vitro: ME0328 was used at 10 µM in vitro and cellular assays.
In vivo: n/a

Reference:

  • 1. Lindgren AE, et al. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3. (2013) ACS Chem Biol. 8(8):1698-703. 
  • 2. Wang H, et al. CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation. (2017) Cancer Lett. 385:137-143. 
  • 3. Day TA, et al. PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA. (2017) Nat Commun. 8:15110. 


ME0328_spec.pdf 
ME0328_MSDS.pdf     

Products are for research use only. Not for human use. 

Reviews

Write Your Review

How do you rate this product? *

Price:
Value:
Quality: